CEO of CoLabs Medical and Co-Founder of Watershed Therapeutics. At CoLabs, he leads development of the VENTOR system to improve outcomes in cardiac arrest and post-resuscitation care. At Watershed, he is advancing novel therapies in urology. With deep expertise in clinical trials, regulatory strategy, and device innovation, Clay focuses on solving high-impact, underserved medical needs through mission-driven innovation.

An attending physician and assistant clinical professor at Stanford University for 23 years. He has started more than 18 medical device companies. Specifically he is the Founder of CoRepair, Inc., NTERO Surgical , and Broncus Technologies where he also served as Chairman. Some of his other previous appointments include founder of Asthmatx (Acquired by Boston Scientific), advisor at Baxano, and founder and board member of Hearten.

Gary oversees operations, strategy, and execution of the company’s clinical and regulatory programs. With extensive leadership experience in medical devices and healthcare operations, Gary drives efficiency and growth while supporting the VENTOR system’s development. He is passionate about building high-performing teams and advancing technologies that improve patient outcomes.